- Issues in the Market
- Key findings
- Definition
- Abbreviations
- Market in Brief
- Growing children' s population, stagnating medicine market
- The impact of MHRA
- Pharmacists play an integral role
- Can' t put a price on health
- Heavily branded market
- Future outlook
- Internal Market Environment
- Key points
- Child health
- Children' s asthma and eczema
- GP consultations in decline
- Figure 1: Average number of NHS GP consultations per person per year, by
gender and age, Great Britain, 1997 to 2007
- Absence from school
- Figure 2: Absence rates as reported in school census, % of days, 2006-08
- The role of the internet
- Figure 3: Broadband usage, by presence of children, 2008
- Figure 4: Influence of the media amongst parents, 2004-08
- Online chemist
- Sources of advice or information
- Figure 5: Sources of advice or information regarding health issues, 2008
- Looking for alternatives
- Broader Market Environment
- Key points
- Child population
- Figure 6: UK child population, by age and gender, 2004-14
- Impact of siblings/family size
- Child immunisation
- Figure 7: Percentage of children immunised by their second birthday,
England 1992/93-2002/03
- Risk of outbreaks rising
- Vaccination, regulation and education
- Changes in legislation
- OTC cold and flu medicines
- Impact for children' s OTC market
- Competitive Context
- Key points
- Market in OTC context
- Prescription medicine
- Healthcare or toiletries?
- Sporting injuries... and celebrities
- Strengths and Weaknesses
- Strengths
- Weaknesses
- Market Size and Forecast
- Key points
- Market growth impeded
- Figure 11: UK retail value sales of children' s OTC and healthcare
products, 2004-14
- Future
- Segment Performance
- Key points
- Sector sales trends
- Figure 12: UK retail value sales of children' s OTC and healthcare
products, by sector, 2007-09
- Market to grow on the defensive?
- MHRA recommendations see market cool
- Prevention rather than cure
- Rash of growth amongst young children
- Fast reactions to opportunities for growth
- Market value by product format
- Figure 13: UK retail value sales of babies' and children' s OTC products,
by format, 2007-09
- Market Share
- Key points
- Retail sales by manufacturer
- Figure 14: Manufacturers' shares in the UK babies' and children' s OTC
market, 2007-09
- The importance of brand promotion
- Fever warms sales
- MHRA impact sales for Reckitt Benckiser
- Trust Boots
- Companies and Products
- Figure 15: Major brands in the UK babies' and children' s OTC market, 2008
- Bayer HealthCare
- Chefaro
- DDD Group
- Forest Labs
- GlaxoSmithKline
- Johnson & Johnson
- Kobayashi
- Novartis
- Reckitt Benckiser
- SSL
- Thornton & Ross
- Other
- Zirtek
- Koolpak
- Schwabe Pharma
- Badger
- Lanes Health
- Nelsons
- Weleda
- Ransom Consumer Healthcare
- Retailer own-labels
- Boots
- Tesco
- Sainsbury
- Brand Communication and Promotion
- Key points
- Topline adspend
- Figure 16: Main monitored media advertising spend on children' s OTC,
2006-09
- Advertiser
- Figure 17: Main monitored media advertising spend on children' s OTC, %
by leading advertiser, 2006-09
- Head lice targeted
- Media type
- Figure 18: Main monitored media advertising spend on children' s OTC, %
by media type, 2006-09
- Channels to Market
- Key points
- Retail distribution of children' s OTC
- Figure 19: Retail distribution of the UK market for children' s OTC,
2007-09
- Chemists and drugstores dominate
- Steady growth for supermarkets
- Healthy growth for low-value health food stores
- Purchase of Non-Prescription Pharmaceuticals
- Key points
- Purchasing habits
- Figure 20: Source of purchase of non-prescription pharmaceuticals and
chemist products, 2006-08
- Healthy profile for supermarkets
- Internet evolves
- Drug stores -- for infant/junior care
- Age and socio-economic status count
- Figure 21: OTC/healthcare shoppers, by demographic group, 2009
- Potential retail initiatives
- Children' s OTC Medicines Purchased in the Last 12 Months
- Key points
- Figure 22: Purchase of children' s medicines and medicated products in
the last 12 months, April 2009
- Parents suffer too
- Figure 23: Illnesses suffered from by adults aged 15+ in the last 12
months by demographics, 2008
- Prescriptive opportunity
- Figure 24: Comparison of influence of recommendation by all parents and
those who have bought a prescribed medicine for their child in the last 12
months, April 2009
- Consumer Purchase Influence
- Key points
- Recommendation is the biggest influence
- Figure 25: Factors that influence the purchase of children' s medicine
and medicated products, April 2009
- Figure 26: Difference in purchase motivation between all parents and
those who are influenced by recommendations, April 2009
- Advertising less effective than word of mouth
- Factoring in function, format and flavour
- No contest between health and wealth
- Appendix
- ACORN
- Advertising data
- Appendix -- Internal Market Environment
- Figure 30: Advice sought on health of children, by age of children, 2008
- Appendix -- Broader Market Environment
- Figure 31: Age of children by individual year, 2009
- Figure 32: Adults aged 15+ who are parent/guardian to any children aged
0-15-year-olds, 2008 & 2009
- Appendix -- Purchase of Non-Prescription Pharmaceuticals
- Figure 33: Purchase of non-prescription pharmaceuticals and chemist
products, 2008
- Appendix -- Children' s OTC Medicines Purchased in the Last 12 Months
- Figure 34: Purchase of children' s medicines and medicated products in
the last 12 months, by demographics, April 2009
- Appendix -- Consumer Purchase Influence
- Figure 35: Most popular factors that influence the purchase of
children' s medicine and medicated products, by demographics, April 2009
- Figure 36: Next most popular factors that influence the purchase of
children' s medicine and medicated products, by demographics, April 2009
(continued)
- Figure 37: Parents who are guided by recommendation from the
doctor/nurse or pharmacist or family/friend, by demographics, April 2009
|
Related Report
|
View Cart
